128 related articles for article (PubMed ID: 15800916)
1. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer.
Wang H; Zhang Z; Li R; Ang KK; Zhang H; Caraway NP; Katz RL; Jiang F
Int J Cancer; 2005 Aug; 116(2):285-90. PubMed ID: 15800916
[TBL] [Abstract][Full Text] [Related]
2. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
Feng G; Xu X; Youssef EM; Lotan R
Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
[TBL] [Abstract][Full Text] [Related]
3. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
4. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.
Diederichs S; Bulk E; Steffen B; Ji P; Tickenbrock L; Lang K; Zänker KS; Metzger R; Schneider PM; Gerke V; Thomas M; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2004 Aug; 64(16):5564-9. PubMed ID: 15313892
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus.
Kyriazanos ID; Tachibana M; Dhar DK; Shibakita M; Ono T; Kohno H; Nagasue N
Oncol Rep; 2002; 9(3):503-10. PubMed ID: 11956617
[TBL] [Abstract][Full Text] [Related]
6. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.
Suzuki F; Oridate N; Homma A; Nakamaru Y; Nagahashi T; Yagi K; Yamaguchi S; Furuta Y; Fukuda S
Oncol Rep; 2005 Dec; 14(6):1493-8. PubMed ID: 16273244
[TBL] [Abstract][Full Text] [Related]
7. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
8. S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy.
Bartling B; Rehbein G; Schmitt WD; Hofmann HS; Silber RE; Simm A
Eur J Cancer; 2007 Sep; 43(13):1935-43. PubMed ID: 17689067
[TBL] [Abstract][Full Text] [Related]
9. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
Strazisar M; Rott T; Glavac D
Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
11. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
[TBL] [Abstract][Full Text] [Related]
14. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
[TBL] [Abstract][Full Text] [Related]
15. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
[TBL] [Abstract][Full Text] [Related]
16. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity.
Wang T; Liang Y; Thakur A; Zhang S; Liu F; Khan H; Shi P; Wang N; Chen M; Ren H
Clin Chim Acta; 2017 Jan; 464():118-122. PubMed ID: 27876462
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma.
Lauriola L; Michetti F; Maggiano N; Galli J; Cadoni G; Schäfer BW; Heizmann CW; Ranelletti FO
Int J Cancer; 2000 Jul; 89(4):345-9. PubMed ID: 10956408
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study.
Golouh R; Cufer T; Sadikov A; Nussdorfer P; Usher PA; Brünner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
Breast Cancer Res Treat; 2008 Jul; 110(2):317-26. PubMed ID: 17874182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
